ロード中...
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
PURPOSE: We set out to determine whether clinically tested epigenetic drugs against class I histone deacetylases (HDACs) affect hallmarks of the metastatic process. METHODS: We treated permanent and primary renal, lung, and breast cancer cells with the class I histone deacetylase inhibitors (HDACi)...
保存先:
| 出版年: | J Cancer Res Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985217/ https://ncbi.nlm.nih.gov/pubmed/31932908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-019-03118-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|